Drug Boosts Muscle Repair in GLP-1 Weight-Loss Mice
Stanford researchers have identified an existing drug that may help GLP-1 weight-loss patients preserve muscle mass. The drug, which targets a specific enzyme, showed promise in mice by improving muscle regeneration without hindering fat loss.
Why it matters
This could address a major side effect of popular weight-loss medications, potentially improving long-term health outcomes for millions of users.
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn't return quickly, and muscle loss can have deleterious effects on strength, mobility and overall health.
The article summarizes scientific research findings objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in